Molecule uses hormones to fight diabetes

Share this article:

A team of researchers say a two-hormone approach to type 2 diabetes appears to reduce sugar levels as well as chip away at obesity. The experimental two-in-one combination fuses a GLP-1 and a gastric inhibitory peptide. Digestive processes naturally trigger these two hormones. Researchers say their simulation maximizes the metabolic impact of these hormones which also influence appetite and fat burning. The study incorporated data from Roche and was published in Science Translational Medicine.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Panel votes against painkiller

Panel chair Randall Flick said QRxPharma "had not provided sufficient evidence to support a claim that Moxduo is safer than morphine or oxycodone."

Amgen sales rose by 5% in Q1

But demand for Enbrel and Aranesp slipped.

FDA reviews new painkiller

The candidate would be the first to put oxycodone and morphine in one capsule.